Navigation Links
Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress

ut Savient's business and the biopharmaceutical and specialty pharmaceutical industries in which Savient operates. Such risks and uncertainties include, but are not limited to, Savient's stock price and market conditions, delay or failure in developing Puricase(R) and other product candidates, difficulties of expanding Savient's product portfolio through in-licensing, introduction of generic competition for Oxandrin(R), fluctuations in buying patterns of wholesalers, potential future returns of Oxandrin or other products, Savient's continuing to incur substantial net losses for the foreseeable future, difficulties in obtaining financing, potential development of alternative technologies or more effective products by competitors, reliance on third-parties to manufacture, market and distribute many of Savient's products, (economic, political and other risks associated with foreign operations) risks of maintaining protection for Savient's intellectual property, risks of an adverse determination in ongoing or future intellectual property litigation, and risks associated with stringent government regulation of the biopharmaceutical industry. Savient may not actually achieve the plans, intentions or expectations disclosed in Savient's forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that Savient makes. Stockholders should not place undue reliance on the forward-looking statements, which speak only as to the date of this press release. Savient's forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments that Savient may make. Except as required by law, Savient does not assume any obligation to update any forward-looking statements.

SVNT-I

Contact

Savient Pharmaceuticals, Inc.
Mary Coleman, 732-418-9300





Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:7/2/2015)... , July 2, 2015 ResMed Inc. (NYSE: ... fourth quarter and fiscal year ended June 30, 2015 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
(Date:7/2/2015)... you head outdoors with your family to enjoy the summer ... Take steps to protect yourself from the sun, bugs and ... Your Skin From the Sun Exposure to ultraviolet ... skin cancer. To protect your skin from UV radiation, stay ... hours. Wear a hat with a wide brim to shade ...
(Date:7/2/2015)... , July 2, 2015 According to ... Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), ... Global Forecast to 2020", published by MarketsandMarkets, the global Neuromodulation ... projected to reach $6.20 Billion by 2020, at a CAGR ... 8 4 market data T ...
Breaking Medicine Technology:ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4
...  Today at the 21st Annual National Mobility Equipment Dealers ... Awareness Month was unveiled, which will be celebrated throughout ... of the awareness month is to teach seniors, veterans ... and mobile lifestyle through the use of wheelchair accessible ...
... 60 Plus Association today sent a letter of gratitude ... contacted the Federal Trade Commission (FTC) with concerns over ... Scripts, Inc. and Medco Health Solutions. The organization made ... of their 7.1 million supporters to defend patient choice, ...
Cached Medicine Technology:NMEDA Introduces National Mobility Awareness Month for Seniors, Veterans and People with Disabilities 260 Plus Association Applauds Opposition to PBM Merger 2
(Date:7/4/2015)... ... 04, 2015 , ... When a hacker gains access to someone’s email account, it can lead ... Wednesday, July 1st, the FTC issued a scam alert about a social engineering scam ... for a password reset instigated by the hacker. All they have to do is ...
(Date:7/3/2015)... ... July 03, 2015 , ... On ... for a new SEO training system called "Page One Engine" . The ... generation has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has ...
(Date:7/3/2015)... ... 2015 , ... B. E. Smith, the only full-service leadership ... national president recruitment for Regional Care, Inc. in Scottsbluff, Neb. One ... has recently placed more than 1,000 healthcare executives into organizations. , As ...
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing clients in ... Talcum Powder Cancer Lawsuit Center website. Just as the previous version did, the new ... offering timely lawsuit updates and ovarian cancer warning information. The site is routinely updated ...
(Date:7/3/2015)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... biblical truth and expose popular lies regarding proper relationships according to the bible. ... goes into the core of the subject by explaining why certain types of sexual ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... used in emergency rooms for decades, can be easily used in ... hospital. The substance is a fine powder form of processed charcoal ... from being absorbed into the bloodstream. Stocked by some pharmacies, it ... and also comes pre-mixed with water. ,Charcoal is ...
... Children with attention-deficit/hyperactivity disorder (ADHD) who use stimulants like ... in life. The study in rats suggests that stimulant ... cocaine in adulthood. // ,Many children and ... best-known being Ritalin. These drugs appear to focus patients' ...
... patients who are depressed are more likely to be re-admitted ... linked to poor physical health, and this relationship may be ... 300 patients on hospital admission, tested then for depression and ... depressed were 40 per cent more likely to be re-admitted ...
... Treatment combining the cholesterol drug simvastatin with the B ... other artery-disease complications by up to 90% in some ... arteries and low HDL (good) cholesterol showed that 3 ... artery blockages to recede and significantly lowered heart complications ...
... to a new study even after getting a shot of ... people who have taken and those have not. Influenza can ... seems like a sensible thing to do. But there have ... worse. To find it this out researchers at Cleavland University ...
... cancer treatments do not realise that future patients are more ... treating cancer - or any other disease - unless there ... trial. Doctors in California gathered views from more than 200 ... that only 60 per cent realised they might not get ...
Cached Medicine News:Health News:Simvastatin Plus Niacin May Lower Heart Risks 2
The best combination with the Haag-Streit 900 Slitlamps. For examination of the entire fundus, the vitreous and the iridocorneal angle. For children up to 4 years of age. 11 mm internal diameter of t...
This contact glass serves to examine the ora serrata, the pars plana and the extreme peripheral parts of the vitreous body and the ocular fundus....
This table provides the user with a moderatelypriced, yet fully versatile, electric table which will accept most HAAG-STREIT instruments as well as many of those from other ophthalmic manufacturers....
... The Biomet® Retrograde ... and offers the advantages ... over short, straight nail ... proximal screws promote ease-of-use ...
Medicine Products: